MEDA

This article is about the psychedelic drug. For the instrument on the Perseverance rover, see Mars Environmental Dynamics Analyzer.

MEDA

Names
Preferred IUPAC name 1-(8-Methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine
Identifiers
CAS Number	23693-25-6 Y
3D model (JSmol)	Interactive image
ChemSpider	24034 Y
KEGG	D03376 Y
PubChem CID	25798
UNII	T2DAA4TB22 Y
InChI InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3 N Key: NRVFDGZJTPCULU-UHFFFAOYSA-N Y InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3 Key: HEYPARQBPGSFKW-UHFFFAOYSA-N
SMILES NC(CC1=CC2=C(OCCO2)C(OC)=C1)C
Properties
Chemical formula	C12H17NO3
Molar mass	223.272 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify (what is YN ?) Infobox references

MEDA (3-methoxy-4,5-ethylenedioxyamphetamine) is a lesser-known psychedelic drug. MEDA was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 200 mg, and the duration unknown. MEDA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MEDA.

See also

• Phenethylamine
• Psychedelics, dissociatives and deliriants